Ignite Creation Date:
2024-07-17 @ 11:20 AM
Last Modification Date:
2024-10-26 @ 3:34 PM
Study NCT ID:
NCT06493604
Status:
RECRUITING
Last Update Posted:
2024-07-10
First Post:
2024-07-02
Brief Title:
A Trial to Assess the Safety and Efficacy of Subjects With Dry Eye Disease
Sponsor:
Aldeyra Therapeutics Inc
Organization:
Aldeyra Therapeutics Inc
Study Overview
Official Title:
A Randomized Double-Masked Vehicle-Controlled Parallel Group Clinical Trial to Assess Efficacy and Safety of 025 Reproxalap Ophthalmic Solution Compared to Vehicle in Subjects With Dry Eye Disease
Status:
RECRUITING
Status Verified Date:
2024-07
Last Known Status:
None
Delayed Posting:
No
If Stopped, Why?:
Not Stopped
Has Expanded Access:
False
If Expanded Access, NCT#:
N/A
Has Expanded Access, NCT# Status:
N/A
Acronym:
None
Brief Summary:
A Randomized Double-Masked Vehicle-Controlled Parallel Group Clinical Trial to Assess Efficacy and Safety of 025 Reproxalap Ophthalmic Solution Compared to Vehicle in Subjects with Dry Eye Disease
Detailed Description:
Dry eye chamber challenge trial
Study Oversight
Has Oversight DMC:
None
Is a FDA Regulated Drug?:
True
Is a FDA Regulated Device?:
False
Is an Unapproved Device?:
None
Is a PPSD?:
None
Is a US Export?:
None
Is an FDA AA801 Violation?:
None